Treatments for platinum-resistant ovarian cancer are expanding with new FDA-approved immunotherapy combinations and targeted ...

Researchers have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments. These findings could lead to personalized therapies that target the right ...

HUNDREDS of women with ovarian cancer will benefit from a new NHS drug in the biggest breakthrough against the disease for ...

Women taking the drug tell the BBC it has given them their lives back.

A new targeted ovarian cancer treatment is helping women with hard-to-treat disease live longer, feel better, and gain ...

High-volume hospitals with frequent NACT use had the lowest 90-day surgical mortality and longest 60-month survival. NACT reduced perioperative deaths in all hospital types, including those with low ...

A rare type of ovarian cancer that grows slowly and responds poorly to chemotherapy now has its first FDA-approved treatment, a combination drug developed by Verastem Oncology to address a pathway ...

Northwestern Medicine scientists have identified a key driver of chemotherapy resistance in advanced ovarian cancer, according to a study published in the Journal of Clinical Investigation. Ovarian ...

A new drug is showing promise in tackling treatment-resistant ovarian cancer. Relacorilant, the drug tested in a phase 3 ROSELLA trial with Corcept Therapeutics in California, was found to improve ...

VIRGINIA BEACH, Va. (WAVY) — Just when Becky Kirby found love, she got the diagnosis. Kirby and her husband were returning from a one-year anniversary trip when she felt the pain in her abdomen that ...